Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017

PLoS One. 2020 Nov 11;15(11):e0241793. doi: 10.1371/journal.pone.0241793. eCollection 2020.

Abstract

Background: Typing of Neisseria meningitidis isolates is crucial for the surveillance of invasive meningococcal disease (IMD). We performed a molecular epidemiology study of N. meningitidis serogroup B (MenB) causing IMD in Italy between 2014 and 2017 to describe circulating strains belonging to this serogroup, with particular regards to the two factor H-binding protein (FHbp) subfamilies present in the bivalent MenB vaccine.

Materials and methods: A total of 109 culture positive and 46 culture negative MenB samples were collected within the National Surveillance System (NSS) of IMD in Italy and molecularly analyzed by conventional methods.

Results: Overall, 71 MenB samples showed the FHbp subfamily A and 83 the subfamily B. The subfamily variants were differently distributed by age. The most frequent variants, A05 and B231, were associated with cc213 and cc162, respectively. All MenB with the FHbp A05 variant displayed the PorA P1.22,14 and 85.7% of them the FetA F5-5. The majority of MenB with the FHbp B231 variant showed the PorA P1.22,14 (65.4%) and 84.6%, the FetA F3-6.

Conclusion: MenB circulating in Italy were characterized by a remarkable association between clonal complex and FHbp variants, although a high degree of genetic diversity observed over time. A dynamic trend in clonal complexes distribution within MenB was detected. Our results stress the importance of continued meningococcal molecular surveillance to evaluate the potential vaccine coverage of the available MenB vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Bacterial / immunology
  • Antigens, Bacterial / metabolism
  • Bacterial Outer Membrane Proteins / immunology
  • Bacterial Outer Membrane Proteins / metabolism
  • Bacterial Proteins / immunology
  • Bacterial Proteins / metabolism
  • Bacterial Vaccines / immunology
  • Genetic Variation
  • Meningococcal Vaccines / immunology
  • Meningococcal Vaccines / metabolism
  • Multilocus Sequence Typing
  • Neisseria meningitidis, Serogroup B / immunology*
  • Neisseria meningitidis, Serogroup B / metabolism
  • Porins / immunology
  • Porins / metabolism
  • Software
  • Whole Genome Sequencing

Substances

  • Antigens, Bacterial
  • Bacterial Outer Membrane Proteins
  • Bacterial Proteins
  • Bacterial Vaccines
  • FrpB protein, bacteria
  • Meningococcal Vaccines
  • Porins
  • factor H-binding protein, Neisseria meningitidis
  • porin protein, Neisseria

Grants and funding

Funded study Initials of the authors who received each award= PS Grant number awarded to each author= W78 The full name of each funder= Pfizer Italia srl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.